Stock Pro

Import alert on SUN PHARMA and HUL's entry into the health and wellness market, know brokerages' view on stocks

SUN PHARMA's Halol plant has given clarification on receiving import alert from US FDA yesterday. The company said that there will be no change in the revenue guidance for FY23. This will not have any impact on the earnings of the specialty segment. We will consider product transfer on a case to case basis. The company said that the terms of supply of 14 products are confidential. Along with this, the company will review the incremental cost to meet the supply. Along with this, we will try to solve the problems soon after meeting the US FDA. At the same time, HUL has shown preparation to enter the health and wellness market. The company has also decided to acquire 100% stake in OZIVA and approximately 20% stake in Nutrition lab. Know what is the brokerage's view on both the stocks-



Bernstein on Sun Pharma: Bernstein has Outperform rating on Sun Firm. He has fixed a target of Rs 1,099 on its stock.

Nomura on Sun Pharma: Nomura has maintained a buy rating on Sun Pharma with a bullish stance. He has fixed a target price of Rs 1,094 on its stock.

MS On Sun Pharma: Morgan Stanley has Overweight rating on Sun Pharma. He has fixed a target of Rs 1150 on this stock.



MS on HUL: MS has given equal weight call on HUL. He has fixed the target of its stock at Rs 2,230 per share.

Nomura on HUL: Nomura has given buy call on Hindustan Unilever. He said that a target price of Rs 3,175 per share will be seen in this.

CLSA on HUL: CLSA has given outperform rating on HUL. He has fixed the target of its stock at Rs 2,950 per share.

Jefferies on HUL: Jefferies has placed a buy call on Hindustan Unilever with a target of Rs 3,050.

Citi on HUL: Citi has given a buy rating on HUL. The brokerage has fixed a target of Rs 3050 on its stock.

Disclaimer: The views and investment advice offered here are the personal views and opinions of investment experts. StockPro advises users to consult certified experts before making any investment decisions.

Request A Call Back

Fill Up The Form and we will call you